Serveur d'exploration sur la rapamycine et les champignons

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Translation control during prolonged mTORC1 inhibition mediated by 4E-BP3.

Identifieur interne : 000970 ( Main/Exploration ); précédent : 000969; suivant : 000971

Translation control during prolonged mTORC1 inhibition mediated by 4E-BP3.

Auteurs : Yoshinori Tsukumo [Canada] ; Tommy Alain [Canada] ; Bruno D. Fonseca [Canada] ; Robert Nadon [Canada] ; Nahum Sonenberg [Canada]

Source :

RBID : pubmed:27319316

Descripteurs français

English descriptors

Abstract

Targeting mTORC1 is a highly promising strategy in cancer therapy. Suppression of mTORC1 activity leads to rapid dephosphorylation of eIF4E-binding proteins (4E-BP1-3) and subsequent inhibition of mRNA translation. However, how the different 4E-BPs affect translation during prolonged use of mTOR inhibitors is not known. Here we show that the expression of 4E-BP3, but not that of 4E-BP1 or 4E-BP2, is transcriptionally induced during prolonged mTORC1 inhibition in vitro and in vivo. Mechanistically, our data reveal that 4E-BP3 expression is controlled by the transcription factor TFE3 through a cis-regulatory element in the EIF4EBP3 gene promoter. CRISPR/Cas9-mediated EIF4EBP3 gene disruption in human cancer cells mitigated the inhibition of translation and proliferation caused by prolonged treatment with mTOR inhibitors. Our findings show that 4E-BP3 is an important effector of mTORC1 and a robust predictive biomarker of therapeutic response to prolonged treatment with mTOR-targeting drugs in cancer.

DOI: 10.1038/ncomms11776
PubMed: 27319316
PubMed Central: PMC4915159


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Translation control during prolonged mTORC1 inhibition mediated by 4E-BP3.</title>
<author>
<name sortKey="Tsukumo, Yoshinori" sort="Tsukumo, Yoshinori" uniqKey="Tsukumo Y" first="Yoshinori" last="Tsukumo">Yoshinori Tsukumo</name>
<affiliation wicri:level="4">
<nlm:affiliation>Department of Biochemistry and Goodman Cancer Research Centre, McGill University, Cancer Pavilion 1160 Pine Avenue West, Montreal, Quebec, Canada H3A 1A3.</nlm:affiliation>
<country>Canada</country>
<wicri:regionArea>Department of Biochemistry and Goodman Cancer Research Centre, McGill University, Cancer Pavilion 1160 Pine Avenue West, Montreal, Quebec</wicri:regionArea>
<orgName type="university">Université McGill</orgName>
<placeName>
<settlement type="city">Montréal</settlement>
<region type="state">Québec</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Alain, Tommy" sort="Alain, Tommy" uniqKey="Alain T" first="Tommy" last="Alain">Tommy Alain</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Biochemistry, Microbiology and Immunology, Children's Hospital of Eastern Ontario Research Institute, University of Ottawa, Ottawa, Ontario, Canada K1H 8L1.</nlm:affiliation>
<country>Canada</country>
<wicri:regionArea>Department of Biochemistry, Microbiology and Immunology, Children's Hospital of Eastern Ontario Research Institute, University of Ottawa, Ottawa, Ontario</wicri:regionArea>
<wicri:noRegion>Ontario</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Fonseca, Bruno D" sort="Fonseca, Bruno D" uniqKey="Fonseca B" first="Bruno D" last="Fonseca">Bruno D. Fonseca</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Biochemistry, Microbiology and Immunology, Children's Hospital of Eastern Ontario Research Institute, University of Ottawa, Ottawa, Ontario, Canada K1H 8L1.</nlm:affiliation>
<country>Canada</country>
<wicri:regionArea>Department of Biochemistry, Microbiology and Immunology, Children's Hospital of Eastern Ontario Research Institute, University of Ottawa, Ottawa, Ontario</wicri:regionArea>
<wicri:noRegion>Ontario</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Nadon, Robert" sort="Nadon, Robert" uniqKey="Nadon R" first="Robert" last="Nadon">Robert Nadon</name>
<affiliation wicri:level="1">
<nlm:affiliation>McGill University and Genome Quebec Innovation Centre, Department of Human Genetics, McGill University, Montreal, Quebec, Canada H3A 1A5.</nlm:affiliation>
<country>Canada</country>
<wicri:regionArea>McGill University and Genome Quebec Innovation Centre, Department of Human Genetics, McGill University, Montreal, Quebec</wicri:regionArea>
<wicri:noRegion>Quebec</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Sonenberg, Nahum" sort="Sonenberg, Nahum" uniqKey="Sonenberg N" first="Nahum" last="Sonenberg">Nahum Sonenberg</name>
<affiliation wicri:level="4">
<nlm:affiliation>Department of Biochemistry and Goodman Cancer Research Centre, McGill University, Cancer Pavilion 1160 Pine Avenue West, Montreal, Quebec, Canada H3A 1A3.</nlm:affiliation>
<country>Canada</country>
<wicri:regionArea>Department of Biochemistry and Goodman Cancer Research Centre, McGill University, Cancer Pavilion 1160 Pine Avenue West, Montreal, Quebec</wicri:regionArea>
<orgName type="university">Université McGill</orgName>
<placeName>
<settlement type="city">Montréal</settlement>
<region type="state">Québec</region>
</placeName>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2016">2016</date>
<idno type="RBID">pubmed:27319316</idno>
<idno type="pmid">27319316</idno>
<idno type="doi">10.1038/ncomms11776</idno>
<idno type="pmc">PMC4915159</idno>
<idno type="wicri:Area/Main/Corpus">000A26</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000A26</idno>
<idno type="wicri:Area/Main/Curation">000A26</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000A26</idno>
<idno type="wicri:Area/Main/Exploration">000A26</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Translation control during prolonged mTORC1 inhibition mediated by 4E-BP3.</title>
<author>
<name sortKey="Tsukumo, Yoshinori" sort="Tsukumo, Yoshinori" uniqKey="Tsukumo Y" first="Yoshinori" last="Tsukumo">Yoshinori Tsukumo</name>
<affiliation wicri:level="4">
<nlm:affiliation>Department of Biochemistry and Goodman Cancer Research Centre, McGill University, Cancer Pavilion 1160 Pine Avenue West, Montreal, Quebec, Canada H3A 1A3.</nlm:affiliation>
<country>Canada</country>
<wicri:regionArea>Department of Biochemistry and Goodman Cancer Research Centre, McGill University, Cancer Pavilion 1160 Pine Avenue West, Montreal, Quebec</wicri:regionArea>
<orgName type="university">Université McGill</orgName>
<placeName>
<settlement type="city">Montréal</settlement>
<region type="state">Québec</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Alain, Tommy" sort="Alain, Tommy" uniqKey="Alain T" first="Tommy" last="Alain">Tommy Alain</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Biochemistry, Microbiology and Immunology, Children's Hospital of Eastern Ontario Research Institute, University of Ottawa, Ottawa, Ontario, Canada K1H 8L1.</nlm:affiliation>
<country>Canada</country>
<wicri:regionArea>Department of Biochemistry, Microbiology and Immunology, Children's Hospital of Eastern Ontario Research Institute, University of Ottawa, Ottawa, Ontario</wicri:regionArea>
<wicri:noRegion>Ontario</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Fonseca, Bruno D" sort="Fonseca, Bruno D" uniqKey="Fonseca B" first="Bruno D" last="Fonseca">Bruno D. Fonseca</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Biochemistry, Microbiology and Immunology, Children's Hospital of Eastern Ontario Research Institute, University of Ottawa, Ottawa, Ontario, Canada K1H 8L1.</nlm:affiliation>
<country>Canada</country>
<wicri:regionArea>Department of Biochemistry, Microbiology and Immunology, Children's Hospital of Eastern Ontario Research Institute, University of Ottawa, Ottawa, Ontario</wicri:regionArea>
<wicri:noRegion>Ontario</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Nadon, Robert" sort="Nadon, Robert" uniqKey="Nadon R" first="Robert" last="Nadon">Robert Nadon</name>
<affiliation wicri:level="1">
<nlm:affiliation>McGill University and Genome Quebec Innovation Centre, Department of Human Genetics, McGill University, Montreal, Quebec, Canada H3A 1A5.</nlm:affiliation>
<country>Canada</country>
<wicri:regionArea>McGill University and Genome Quebec Innovation Centre, Department of Human Genetics, McGill University, Montreal, Quebec</wicri:regionArea>
<wicri:noRegion>Quebec</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Sonenberg, Nahum" sort="Sonenberg, Nahum" uniqKey="Sonenberg N" first="Nahum" last="Sonenberg">Nahum Sonenberg</name>
<affiliation wicri:level="4">
<nlm:affiliation>Department of Biochemistry and Goodman Cancer Research Centre, McGill University, Cancer Pavilion 1160 Pine Avenue West, Montreal, Quebec, Canada H3A 1A3.</nlm:affiliation>
<country>Canada</country>
<wicri:regionArea>Department of Biochemistry and Goodman Cancer Research Centre, McGill University, Cancer Pavilion 1160 Pine Avenue West, Montreal, Quebec</wicri:regionArea>
<orgName type="university">Université McGill</orgName>
<placeName>
<settlement type="city">Montréal</settlement>
<region type="state">Québec</region>
</placeName>
</affiliation>
</author>
</analytic>
<series>
<title level="j">Nature communications</title>
<idno type="eISSN">2041-1723</idno>
<imprint>
<date when="2016" type="published">2016</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Adaptor Proteins, Signal Transducing (genetics)</term>
<term>Adaptor Proteins, Signal Transducing (metabolism)</term>
<term>Animals (MeSH)</term>
<term>Antibiotics, Antineoplastic (pharmacology)</term>
<term>Basic Helix-Loop-Helix Leucine Zipper Transcription Factors (genetics)</term>
<term>Basic Helix-Loop-Helix Leucine Zipper Transcription Factors (metabolism)</term>
<term>Breast Neoplasms (genetics)</term>
<term>Breast Neoplasms (metabolism)</term>
<term>Breast Neoplasms (mortality)</term>
<term>Breast Neoplasms (pathology)</term>
<term>CRISPR-Cas Systems (MeSH)</term>
<term>Carrier Proteins (genetics)</term>
<term>Carrier Proteins (metabolism)</term>
<term>Cell Proliferation (MeSH)</term>
<term>Databases, Genetic (MeSH)</term>
<term>Eukaryotic Initiation Factors (genetics)</term>
<term>Eukaryotic Initiation Factors (metabolism)</term>
<term>Female (MeSH)</term>
<term>Gene Editing (methods)</term>
<term>Gene Expression Regulation, Neoplastic (MeSH)</term>
<term>HeLa Cells (MeSH)</term>
<term>Hep G2 Cells (MeSH)</term>
<term>Humans (MeSH)</term>
<term>Indoles (pharmacology)</term>
<term>MCF-7 Cells (MeSH)</term>
<term>Male (MeSH)</term>
<term>Mice (MeSH)</term>
<term>Mice, Inbred C57BL (MeSH)</term>
<term>Phosphoproteins (genetics)</term>
<term>Phosphoproteins (metabolism)</term>
<term>Protein Biosynthesis (MeSH)</term>
<term>Purines (pharmacology)</term>
<term>Signal Transduction (MeSH)</term>
<term>Sirolimus (pharmacology)</term>
<term>Survival Analysis (MeSH)</term>
<term>TOR Serine-Threonine Kinases (antagonists & inhibitors)</term>
<term>TOR Serine-Threonine Kinases (genetics)</term>
<term>TOR Serine-Threonine Kinases (metabolism)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Analyse de survie (MeSH)</term>
<term>Animaux (MeSH)</term>
<term>Antibiotiques antinéoplasiques (pharmacologie)</term>
<term>Bases de données génétiques (MeSH)</term>
<term>Biosynthèse des protéines (MeSH)</term>
<term>Cellules HeLa (MeSH)</term>
<term>Cellules HepG2 (MeSH)</term>
<term>Cellules MCF-7 (MeSH)</term>
<term>Facteurs d'initiation eucaryotes (génétique)</term>
<term>Facteurs d'initiation eucaryotes (métabolisme)</term>
<term>Facteurs de transcription à motifs basiques hélice-boucle-hélice et à glissière à leucines (génétique)</term>
<term>Facteurs de transcription à motifs basiques hélice-boucle-hélice et à glissière à leucines (métabolisme)</term>
<term>Femelle (MeSH)</term>
<term>Humains (MeSH)</term>
<term>Indoles (pharmacologie)</term>
<term>Mâle (MeSH)</term>
<term>Phosphoprotéines (génétique)</term>
<term>Phosphoprotéines (métabolisme)</term>
<term>Prolifération cellulaire (MeSH)</term>
<term>Protéines adaptatrices de la transduction du signal (génétique)</term>
<term>Protéines adaptatrices de la transduction du signal (métabolisme)</term>
<term>Protéines de transport (génétique)</term>
<term>Protéines de transport (métabolisme)</term>
<term>Purines (pharmacologie)</term>
<term>Régulation de l'expression des gènes tumoraux (MeSH)</term>
<term>Sirolimus (pharmacologie)</term>
<term>Souris (MeSH)</term>
<term>Souris de lignée C57BL (MeSH)</term>
<term>Systèmes CRISPR-Cas (MeSH)</term>
<term>Sérine-thréonine kinases TOR (antagonistes et inhibiteurs)</term>
<term>Sérine-thréonine kinases TOR (génétique)</term>
<term>Sérine-thréonine kinases TOR (métabolisme)</term>
<term>Transduction du signal (MeSH)</term>
<term>Tumeurs du sein (anatomopathologie)</term>
<term>Tumeurs du sein (génétique)</term>
<term>Tumeurs du sein (mortalité)</term>
<term>Tumeurs du sein (métabolisme)</term>
<term>Édition de gène (méthodes)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="antagonists & inhibitors" xml:lang="en">
<term>TOR Serine-Threonine Kinases</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="genetics" xml:lang="en">
<term>Adaptor Proteins, Signal Transducing</term>
<term>Basic Helix-Loop-Helix Leucine Zipper Transcription Factors</term>
<term>Carrier Proteins</term>
<term>Eukaryotic Initiation Factors</term>
<term>Phosphoproteins</term>
<term>TOR Serine-Threonine Kinases</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en">
<term>Adaptor Proteins, Signal Transducing</term>
<term>Basic Helix-Loop-Helix Leucine Zipper Transcription Factors</term>
<term>Carrier Proteins</term>
<term>Eukaryotic Initiation Factors</term>
<term>Phosphoproteins</term>
<term>TOR Serine-Threonine Kinases</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="pharmacology" xml:lang="en">
<term>Antibiotics, Antineoplastic</term>
<term>Indoles</term>
<term>Purines</term>
<term>Sirolimus</term>
</keywords>
<keywords scheme="MESH" qualifier="anatomopathologie" xml:lang="fr">
<term>Tumeurs du sein</term>
</keywords>
<keywords scheme="MESH" qualifier="antagonistes et inhibiteurs" xml:lang="fr">
<term>Sérine-thréonine kinases TOR</term>
</keywords>
<keywords scheme="MESH" qualifier="genetics" xml:lang="en">
<term>Breast Neoplasms</term>
</keywords>
<keywords scheme="MESH" qualifier="génétique" xml:lang="fr">
<term>Facteurs d'initiation eucaryotes</term>
<term>Facteurs de transcription à motifs basiques hélice-boucle-hélice et à glissière à leucines</term>
<term>Phosphoprotéines</term>
<term>Protéines adaptatrices de la transduction du signal</term>
<term>Protéines de transport</term>
<term>Sérine-thréonine kinases TOR</term>
<term>Tumeurs du sein</term>
</keywords>
<keywords scheme="MESH" qualifier="metabolism" xml:lang="en">
<term>Breast Neoplasms</term>
</keywords>
<keywords scheme="MESH" qualifier="methods" xml:lang="en">
<term>Gene Editing</term>
</keywords>
<keywords scheme="MESH" qualifier="mortality" xml:lang="en">
<term>Breast Neoplasms</term>
</keywords>
<keywords scheme="MESH" qualifier="mortalité" xml:lang="fr">
<term>Tumeurs du sein</term>
</keywords>
<keywords scheme="MESH" qualifier="métabolisme" xml:lang="fr">
<term>Facteurs d'initiation eucaryotes</term>
<term>Facteurs de transcription à motifs basiques hélice-boucle-hélice et à glissière à leucines</term>
<term>Phosphoprotéines</term>
<term>Protéines adaptatrices de la transduction du signal</term>
<term>Protéines de transport</term>
<term>Sérine-thréonine kinases TOR</term>
<term>Tumeurs du sein</term>
</keywords>
<keywords scheme="MESH" qualifier="méthodes" xml:lang="fr">
<term>Édition de gène</term>
</keywords>
<keywords scheme="MESH" qualifier="pathology" xml:lang="en">
<term>Breast Neoplasms</term>
</keywords>
<keywords scheme="MESH" qualifier="pharmacologie" xml:lang="fr">
<term>Antibiotiques antinéoplasiques</term>
<term>Indoles</term>
<term>Purines</term>
<term>Sirolimus</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Animals</term>
<term>CRISPR-Cas Systems</term>
<term>Cell Proliferation</term>
<term>Databases, Genetic</term>
<term>Female</term>
<term>Gene Expression Regulation, Neoplastic</term>
<term>HeLa Cells</term>
<term>Hep G2 Cells</term>
<term>Humans</term>
<term>MCF-7 Cells</term>
<term>Male</term>
<term>Mice</term>
<term>Mice, Inbred C57BL</term>
<term>Protein Biosynthesis</term>
<term>Signal Transduction</term>
<term>Survival Analysis</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Analyse de survie</term>
<term>Animaux</term>
<term>Bases de données génétiques</term>
<term>Biosynthèse des protéines</term>
<term>Cellules HeLa</term>
<term>Cellules HepG2</term>
<term>Cellules MCF-7</term>
<term>Femelle</term>
<term>Humains</term>
<term>Mâle</term>
<term>Prolifération cellulaire</term>
<term>Régulation de l'expression des gènes tumoraux</term>
<term>Souris</term>
<term>Souris de lignée C57BL</term>
<term>Systèmes CRISPR-Cas</term>
<term>Transduction du signal</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Targeting mTORC1 is a highly promising strategy in cancer therapy. Suppression of mTORC1 activity leads to rapid dephosphorylation of eIF4E-binding proteins (4E-BP1-3) and subsequent inhibition of mRNA translation. However, how the different 4E-BPs affect translation during prolonged use of mTOR inhibitors is not known. Here we show that the expression of 4E-BP3, but not that of 4E-BP1 or 4E-BP2, is transcriptionally induced during prolonged mTORC1 inhibition in vitro and in vivo. Mechanistically, our data reveal that 4E-BP3 expression is controlled by the transcription factor TFE3 through a cis-regulatory element in the EIF4EBP3 gene promoter. CRISPR/Cas9-mediated EIF4EBP3 gene disruption in human cancer cells mitigated the inhibition of translation and proliferation caused by prolonged treatment with mTOR inhibitors. Our findings show that 4E-BP3 is an important effector of mTORC1 and a robust predictive biomarker of therapeutic response to prolonged treatment with mTOR-targeting drugs in cancer.</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="MEDLINE" Owner="NLM">
<PMID Version="1">27319316</PMID>
<DateCompleted>
<Year>2018</Year>
<Month>08</Month>
<Day>21</Day>
</DateCompleted>
<DateRevised>
<Year>2018</Year>
<Month>12</Month>
<Day>11</Day>
</DateRevised>
<Article PubModel="Electronic">
<Journal>
<ISSN IssnType="Electronic">2041-1723</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>7</Volume>
<PubDate>
<Year>2016</Year>
<Month>06</Month>
<Day>20</Day>
</PubDate>
</JournalIssue>
<Title>Nature communications</Title>
<ISOAbbreviation>Nat Commun</ISOAbbreviation>
</Journal>
<ArticleTitle>Translation control during prolonged mTORC1 inhibition mediated by 4E-BP3.</ArticleTitle>
<Pagination>
<MedlinePgn>11776</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1038/ncomms11776</ELocationID>
<Abstract>
<AbstractText>Targeting mTORC1 is a highly promising strategy in cancer therapy. Suppression of mTORC1 activity leads to rapid dephosphorylation of eIF4E-binding proteins (4E-BP1-3) and subsequent inhibition of mRNA translation. However, how the different 4E-BPs affect translation during prolonged use of mTOR inhibitors is not known. Here we show that the expression of 4E-BP3, but not that of 4E-BP1 or 4E-BP2, is transcriptionally induced during prolonged mTORC1 inhibition in vitro and in vivo. Mechanistically, our data reveal that 4E-BP3 expression is controlled by the transcription factor TFE3 through a cis-regulatory element in the EIF4EBP3 gene promoter. CRISPR/Cas9-mediated EIF4EBP3 gene disruption in human cancer cells mitigated the inhibition of translation and proliferation caused by prolonged treatment with mTOR inhibitors. Our findings show that 4E-BP3 is an important effector of mTORC1 and a robust predictive biomarker of therapeutic response to prolonged treatment with mTOR-targeting drugs in cancer.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Tsukumo</LastName>
<ForeName>Yoshinori</ForeName>
<Initials>Y</Initials>
<AffiliationInfo>
<Affiliation>Department of Biochemistry and Goodman Cancer Research Centre, McGill University, Cancer Pavilion 1160 Pine Avenue West, Montreal, Quebec, Canada H3A 1A3.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Alain</LastName>
<ForeName>Tommy</ForeName>
<Initials>T</Initials>
<AffiliationInfo>
<Affiliation>Department of Biochemistry, Microbiology and Immunology, Children's Hospital of Eastern Ontario Research Institute, University of Ottawa, Ottawa, Ontario, Canada K1H 8L1.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Fonseca</LastName>
<ForeName>Bruno D</ForeName>
<Initials>BD</Initials>
<AffiliationInfo>
<Affiliation>Department of Biochemistry, Microbiology and Immunology, Children's Hospital of Eastern Ontario Research Institute, University of Ottawa, Ottawa, Ontario, Canada K1H 8L1.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Nadon</LastName>
<ForeName>Robert</ForeName>
<Initials>R</Initials>
<AffiliationInfo>
<Affiliation>McGill University and Genome Quebec Innovation Centre, Department of Human Genetics, McGill University, Montreal, Quebec, Canada H3A 1A5.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Sonenberg</LastName>
<ForeName>Nahum</ForeName>
<Initials>N</Initials>
<AffiliationInfo>
<Affiliation>Department of Biochemistry and Goodman Cancer Research Centre, McGill University, Cancer Pavilion 1160 Pine Avenue West, Montreal, Quebec, Canada H3A 1A3.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2016</Year>
<Month>06</Month>
<Day>20</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>England</Country>
<MedlineTA>Nat Commun</MedlineTA>
<NlmUniqueID>101528555</NlmUniqueID>
<ISSNLinking>2041-1723</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D048868">Adaptor Proteins, Signal Transducing</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000903">Antibiotics, Antineoplastic</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D051778">Basic Helix-Loop-Helix Leucine Zipper Transcription Factors</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D002352">Carrier Proteins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C087000">EIF4EBP1 protein, human</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C104151">EIF4EBP2 protein, human</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C112661">EIF4EBP3 protein, human</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D039642">Eukaryotic Initiation Factors</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D007211">Indoles</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D010750">Phosphoproteins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D011687">Purines</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C069203">TFE3 protein, human</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 2.7.1.1</RegistryNumber>
<NameOfSubstance UI="C546842">MTOR protein, human</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 2.7.1.1</RegistryNumber>
<NameOfSubstance UI="D058570">TOR Serine-Threonine Kinases</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>H5669VNZ7V</RegistryNumber>
<NameOfSubstance UI="C572919">PP242</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>W36ZG6FT64</RegistryNumber>
<NameOfSubstance UI="D020123">Sirolimus</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName UI="D048868" MajorTopicYN="N">Adaptor Proteins, Signal Transducing</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000903" MajorTopicYN="N">Antibiotics, Antineoplastic</DescriptorName>
<QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D051778" MajorTopicYN="N">Basic Helix-Loop-Helix Leucine Zipper Transcription Factors</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D001943" MajorTopicYN="N">Breast Neoplasms</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
<QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName>
<QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D064113" MajorTopicYN="N">CRISPR-Cas Systems</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D002352" MajorTopicYN="N">Carrier Proteins</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D049109" MajorTopicYN="N">Cell Proliferation</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D030541" MajorTopicYN="N">Databases, Genetic</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D039642" MajorTopicYN="N">Eukaryotic Initiation Factors</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000072669" MajorTopicYN="N">Gene Editing</DescriptorName>
<QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D015972" MajorTopicYN="Y">Gene Expression Regulation, Neoplastic</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006367" MajorTopicYN="N">HeLa Cells</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D056945" MajorTopicYN="N">Hep G2 Cells</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D007211" MajorTopicYN="N">Indoles</DescriptorName>
<QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D061986" MajorTopicYN="N">MCF-7 Cells</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008810" MajorTopicYN="N">Mice, Inbred C57BL</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D010750" MajorTopicYN="N">Phosphoproteins</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D014176" MajorTopicYN="N">Protein Biosynthesis</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D011687" MajorTopicYN="N">Purines</DescriptorName>
<QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D015398" MajorTopicYN="N">Signal Transduction</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D020123" MajorTopicYN="N">Sirolimus</DescriptorName>
<QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D016019" MajorTopicYN="N">Survival Analysis</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D058570" MajorTopicYN="N">TOR Serine-Threonine Kinases</DescriptorName>
<QualifierName UI="Q000037" MajorTopicYN="N">antagonists & inhibitors</QualifierName>
<QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="received">
<Year>2015</Year>
<Month>10</Month>
<Day>29</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted">
<Year>2016</Year>
<Month>04</Month>
<Day>27</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2016</Year>
<Month>6</Month>
<Day>21</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2016</Year>
<Month>6</Month>
<Day>21</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2018</Year>
<Month>8</Month>
<Day>22</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>epublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">27319316</ArticleId>
<ArticleId IdType="pii">ncomms11776</ArticleId>
<ArticleId IdType="doi">10.1038/ncomms11776</ArticleId>
<ArticleId IdType="pmc">PMC4915159</ArticleId>
</ArticleIdList>
<ReferenceList>
<Reference>
<Citation>J Clin Oncol. 2011 Aug 20;29(24):3293-300</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21768474</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Mol Cell Biol. 2002 Mar;22(6):1674-83</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11865047</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Oncogene. 2000 Jan 6;19(1):69-74</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">10644981</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Biol Chem. 2009 Mar 20;284(12):8023-32</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19150980</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cell. 2013 Sep 12;154(6):1380-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23992846</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Genes Dev. 1994 Nov 15;8(22):2770-80</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">7958932</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Sci Signal. 2012 Jun 12;5(228):ra42</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22692423</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nature. 1994 Oct 27;371(6500):762-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">7935836</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>EMBO J. 2012 Mar 7;31(5):1095-108</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22343943</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Mol Cell. 2006 Apr 21;22(2):159-68</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16603397</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cancer Res. 2007 Feb 1;67(3):919-29</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17283122</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nature. 2012 Feb 22;485(7396):55-61</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22367541</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Cell Sci. 2014 Feb 15;127(Pt 4):788-800</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24363449</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Proc Natl Acad Sci U S A. 2011 Sep 13;108(37):E699-708</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21876152</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cancer Res. 2008 Feb 1;68(3):631-4</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18245460</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nat Rev Drug Discov. 2011 Oct 31;10(11):868-80</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22037041</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Pancreas. 1994 Jan;9(1):83-90</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">8108375</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Biol Chem. 1998 May 29;273(22):14002-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">9593750</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Biol Chem. 2006 Aug 25;281(34):24293-303</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16798736</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Am J Pathol. 2001 Jul;159(1):179-92</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11438465</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cell Death Dis. 2012 Feb 02;3:266</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22297294</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nat Med. 2006 Jan;12 (1):107-13</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16327801</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Sci Signal. 2014 Jan 21;7(309):ra9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24448649</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cancer Res. 2007 Nov 15;67(22):10804-12</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18006825</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Genes Dev. 1999 Jun 1;13(11):1422-37</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">10364159</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cancer Res. 2007 Aug 15;67(16):7551-5</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17699757</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nature. 2007 Nov 29;450(7170):736-40</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18046414</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cell. 2002 Jul 26;110(2):177-89</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12150926</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Science. 2011 Mar 4;331(6021):1199-203</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21252315</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>EMBO Mol Med. 2015 Apr 01;7(6):735-53</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25834145</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nat Rev Mol Cell Biol. 2011 Jan;12(1):21-35</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21157483</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>N Engl J Med. 2007 May 31;356(22):2271-81</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17538086</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Sci Signal. 2013 Apr 02;6(269):pl1</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23550210</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Mol Cell. 2012 Jun 29;46(6):847-58</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22578813</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Mol Cell Biol. 1998 Dec;18(12):6930-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">9819381</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Am J Surg Pathol. 2003 Jun;27(6):750-61</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12766578</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Histochem Cell Biol. 2008 Sep;130(3):465-71</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18648845</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cell. 2009 Feb 20;136(4):731-45</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19239892</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Sci Signal. 2015 Nov 17;8(403):ra116</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26577921</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Oncogene. 2001 Jan 4;20(1):48-57</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11244503</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cell. 2006 Feb 10;124(3):471-84</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16469695</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Oncogene. 1997 Oct;15(18):2233-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">9393982</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Sci Transl Med. 2012 Jun 20;4(139):139ra84</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22539746</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cancer Res. 2012 Dec 15;72(24):6468-76</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23100465</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Clin Cancer Res. 2008 Mar 15;14(6):1744-52</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18347175</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Biol Chem. 2002 Dec 27;277(52):50286-92</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12381739</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Mol Cell Biol. 2001 Dec;21(24):8357-64</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11713272</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>N Engl J Med. 2011 Feb 10;364(6):514-23</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21306238</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cell. 2012 Apr 13;149(2):274-93</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22500797</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cold Spring Harb Perspect Biol. 2012 Nov 01;4(11):null</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22888049</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Semin Cell Dev Biol. 2014 Dec;36:102-12</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25263010</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nature. 2012 May 02;485(7396):109-13</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22552098</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Science. 2010 May 28;328(5982):1172-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20508131</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cancer Discov. 2012 May;2(5):401-4</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22588877</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cell Metab. 2013 Nov 5;18(5):698-711</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24206664</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nat Methods. 2009 Apr;6(4):275-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19305406</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Genes Dev. 2001 Apr 1;15(7):807-26</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11297505</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nat Rev Drug Discov. 2015 Apr;14(4):261-78</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25743081</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cell. 2002 Jul 26;110(2):163-75</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12150925</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Clin Oncol. 2011 Sep 1;29(25):3474-82</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21670463</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nat Protoc. 2013 Nov;8(11):2281-308</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24157548</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Genes Dev. 1998 Oct 1;12(19):3084-95</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">9765209</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Curr Biol. 2004 Jul 27;14(14):1296-302</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15268862</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Clin Cancer Res. 2007 Jan 1;13(1):81-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17200342</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>PLoS Biol. 2009 Feb 10;7(2):e38</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19209957</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Clin Oncol. 2008 Apr 1;26(10):1603-10</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18332469</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Biol Chem. 2003 Dec 26;278(52):52290-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">14557257</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
<affiliations>
<list>
<country>
<li>Canada</li>
</country>
<region>
<li>Québec</li>
</region>
<settlement>
<li>Montréal</li>
</settlement>
<orgName>
<li>Université McGill</li>
</orgName>
</list>
<tree>
<country name="Canada">
<region name="Québec">
<name sortKey="Tsukumo, Yoshinori" sort="Tsukumo, Yoshinori" uniqKey="Tsukumo Y" first="Yoshinori" last="Tsukumo">Yoshinori Tsukumo</name>
</region>
<name sortKey="Alain, Tommy" sort="Alain, Tommy" uniqKey="Alain T" first="Tommy" last="Alain">Tommy Alain</name>
<name sortKey="Fonseca, Bruno D" sort="Fonseca, Bruno D" uniqKey="Fonseca B" first="Bruno D" last="Fonseca">Bruno D. Fonseca</name>
<name sortKey="Nadon, Robert" sort="Nadon, Robert" uniqKey="Nadon R" first="Robert" last="Nadon">Robert Nadon</name>
<name sortKey="Sonenberg, Nahum" sort="Sonenberg, Nahum" uniqKey="Sonenberg N" first="Nahum" last="Sonenberg">Nahum Sonenberg</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Bois/explor/RapamycinFungusV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000970 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000970 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Bois
   |area=    RapamycinFungusV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:27319316
   |texte=   Translation control during prolonged mTORC1 inhibition mediated by 4E-BP3.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:27319316" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a RapamycinFungusV1 

Wicri

This area was generated with Dilib version V0.6.38.
Data generation: Thu Nov 19 21:55:41 2020. Site generation: Thu Nov 19 22:00:39 2020